{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:00:15Z","timestamp":1780718415302,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"DOI":"10.7759\/cureus.110324","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:05:57Z","timestamp":1780715157000},"source":"Crossref","is-referenced-by-count":0,"title":["Non-cryopreserved Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma in a Resource-Limited Setting: Feasibility, Engraftment Kinetics, and Early Outcomes From Kashmir, India"],"prefix":"10.7759","author":[{"given":"Mohmad Hussain","family":"Mir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail","family":"Ahmad Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh","family":"Muzamil Manzoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajas","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Siraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisar Ahmad","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal R","family":"Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeeza H","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskaran","family":"Singh Sarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshan","family":"Atta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik T","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushtaq Ahmad","family":"Sofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubiya","family":"Ryhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Zubair","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumyra Khurshid","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K","family":"Regmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulfat","family":"Ara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashwat","family":"Lohia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Sultan Lone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazir Ahmad","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip T","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, et al.. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 1995, 333:1540-1545. 10.1056\/NEJM199512073332305","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92411-l","article-title":"Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin disease: results of a BNLI randomised trial","volume":"341","author":"Linch DC","year":"1993","unstructured":"Linch DC, Winfield D, Goldstone AH, et al.. Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin disease: results of a BNLI randomised trial. Lancet. 1993, 341:1051-1054. 10.1016\/0140-6736(93)92411-l","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08938-9","article-title":"Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin disease: a randomised trial","volume":"359","author":"Schmitz N","year":"2002","unstructured":"Schmitz N, Pfistner B, Sextro M, et al.. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin disease: a randomised trial. Lancet. 2002, 359:2065-2071. 10.1016\/S0140-6736(02)08938-9","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.3.723.723","article-title":"Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy","volume":"71","author":"Kessinger A","year":"1988","unstructured":"Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood. 1988, 71:723-727. 10.1182\/blood.V71.3.723.723","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0308-2261(86)80004-2","article-title":"Collection, manipulation and freezing of haemopoietic stem cells","volume":"15","author":"Gorin NC","year":"1986","unstructured":"Gorin NC. Collection, manipulation and freezing of haemopoietic stem cells. Clin Haematol. 1986, 15:19-48. 10.1016\/s0308-2261(86)80004-2","journal-title":"Clin Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-02278-5","article-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","author":"Wuchter P","year":"2019","unstructured":"Wuchter P. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. Carreras E, Dufour C, Mohty M, Kroger N (ed): Springer, Cham; 2019. 10.1007\/978-3-030-02278-5"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm069","article-title":"Feasibility and safety of autotransplants with noncryopreserved marrow or peripheral blood stem cells: a systematic review","volume":"18","author":"Wannesson L","year":"2007","unstructured":"Wannesson L, Panzarella T, Mikhael J, Keating A. Feasibility and safety of autotransplants with noncryopreserved marrow or peripheral blood stem cells: a systematic review. Ann Oncol. 2007, 18:623-632. 10.1093\/annonc\/mdm069","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/917361","article-title":"Autologous hematopoietic stem cell transplantation for multiple myeloma without cryopreservation","volume":"2012","author":"Al-Anazi KA","year":"2012","unstructured":"Al-Anazi KA. Autologous hematopoietic stem cell transplantation for multiple myeloma without cryopreservation. Bone Marrow Res. 2012, 2012:917361. 10.1155\/2012\/917361","journal-title":"Bone Marrow Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.05.013","article-title":"High-dose chemotherapy plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed Hodgkin disease","volume":"12","author":"Mabed M","year":"2006","unstructured":"Mabed M, Shamaa S. High-dose chemotherapy plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed Hodgkin disease. Biol Blood Marrow Transplant. 2006, 12:942-948. 10.1016\/j.bbmt.2006.05.013","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705314","article-title":"Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas","volume":"37","author":"Mabed M","year":"2006","unstructured":"Mabed M, Al-Kgodary T. Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas. Bone Marrow Transplant. 2006, 37:739-743. 10.1038\/sj.bmt.1705314","journal-title":"Bone Marrow Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0174-9","article-title":"Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma","volume":"53","author":"Naithani R","year":"2018","unstructured":"Naithani R, Dayal N, Pathak S, Rai R. Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma. Bone Marrow Transplant. 2018, 53:1198-1200. 10.1038\/s41409-018-0174-9","journal-title":"Bone Marrow Transplant"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2020.03.006","article-title":"Non-cryopreserved peripheral blood stem cells autologous transplantation in multiple myeloma: bicentric study","volume":"27","author":"Jennane S","year":"2020","unstructured":"Jennane S, Hasnaoui N, Mahtat EM, et al.. Non-cryopreserved peripheral blood stem cells autologous transplantation in multiple myeloma: bicentric study. Transfus Clin Biol. 2020, 27:152-156. 10.1016\/j.tracli.2020.03.006","journal-title":"Transfus Clin Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2020.12.016","article-title":"Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry","volume":"23","author":"Bekadja MA","year":"2021","unstructured":"Bekadja MA, Boumendil A, Blaise D, et al.. Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry. Cytotherapy. 2021, 23:483-487. 10.1016\/j.jcyt.2020.12.016","journal-title":"Cytotherapy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2023.04.001","article-title":"Autologous stem cell transplant in lymphoma using a noncryopreserved platform: an adapted sequential conditioning maintaining dose intensity does not affect transplantation outcomes","volume":"23","author":"Sarmiento M","year":"2023","unstructured":"Sarmiento M, Rojas P, Gutierrez C, et al.. Autologous stem cell transplant in lymphoma using a noncryopreserved platform: an adapted sequential conditioning maintaining dose intensity does not affect transplantation outcomes. Clin Lymphoma Myeloma Leuk. 2023, 23:545-551. 10.1016\/j.clml.2023.04.001","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02431-y","article-title":"Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation","volume":"60","author":"Bekadja MA","year":"2025","unstructured":"Bekadja MA, Niederwieser D, Kharfan-Dabaja MA, et al.. Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation. Bone Marrow Transplant. 2025, 60:19-27. 10.1038\/s41409-024-02431-y","journal-title":"Bone Marrow Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-017-0047-7","article-title":"Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas","volume":"53","author":"Kardduss-Urueta A","year":"2018","unstructured":"Kardduss-Urueta A, Gale RP, Gutierrez-Aguirre CH, et al.. Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas. Bone Marrow Transplant. 2018, 53:457-460. 10.1038\/s41409-017-0047-7","journal-title":"Bone Marrow Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.08.007","article-title":"Use of non-cryopreserved peripheral blood stem cells is associated with adequate engraftment in patients with multiple myeloma undergoing an autologous transplant","volume":"24","author":"Kulkarni U","year":"2018","unstructured":"Kulkarni U, Devasia AJ, Korula A, et al.. Use of non-cryopreserved peripheral blood stem cells is associated with adequate engraftment in patients with multiple myeloma undergoing an autologous transplant. Biol Blood Marrow Transplant. 2018, 24:e31-e35. 10.1016\/j.bbmt.2018.08.007","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0117-5","article-title":"Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy","volume":"53","author":"Sarmiento M","year":"2018","unstructured":"Sarmiento M, Ram\u00edrez P, Parody R, et al.. Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy. Bone Marrow Transplant. 2018, 53:960-966. 10.1038\/s41409-018-0117-5","journal-title":"Bone Marrow Transplant"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.938595","article-title":"Non-cryopreserved peripheral blood stem cell graft for autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma patients","volume":"28","author":"Noiperm P","year":"2023","unstructured":"Noiperm P, Julamanee J, Viboonjuntra P, Lekhakula A. Non-cryopreserved peripheral blood stem cell graft for autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma patients. Ann Transplant. 2023, 28:e938595. 10.12659\/AOT.938595","journal-title":"Ann Transplant"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson BD","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014, 32:3059-3068. 10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt S","year":"2014","unstructured":"Giralt S, Costa L, Schriber J, et al.. Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. Biol Blood Marrow Transplant. 2014, 20:295-308. 10.1016\/j.bbmt.2013.10.013","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.927084","article-title":"Outcomes of non-cryopreserved versus cryopreserved peripheral blood stem cells for autologous stem cell transplantation in multiple myeloma","volume":"25","author":"Piriyakhuntorn P","year":"2020","unstructured":"Piriyakhuntorn P, Tantiworawit A, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L. Outcomes of non-cryopreserved versus cryopreserved peripheral blood stem cells for autologous stem cell transplantation in multiple myeloma. Ann Transplant. 2020, 25:e927084. 10.12659\/AOT.927084","journal-title":"Ann Transplant"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror ML","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005, 106:2912-2919. 10.1182\/blood-2005-05-2004","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0516-2","article-title":"Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019","volume":"54","author":"Duarte RF","year":"2019","unstructured":"Duarte RF, Labopin M, Bader P, et al.. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant. 2019, 54:1525-1552. 10.1038\/s41409-019-0516-2","journal-title":"Bone Marrow Transplant"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-44080-9","article-title":"Indications for hematopoietic cell transplantation and immune effector cell therapy: the EBMT Handbook and current practice","volume":"55","author":"Sureda A","year":"2020","unstructured":"Sureda A, Bader P, Cesaro S, et al.. Indications for hematopoietic cell transplantation and immune effector cell therapy: the EBMT Handbook and current practice. Bone Marrow Transplant. 2020, 55:2075-2091. 10.1007\/978-3-031-44080-9","journal-title":"Bone Marrow Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499760-non-cryopreserved-autologous-peripheral-blood-stem-cell-transplantation-for-lymphoma-in-a-resource-limited-setting-feasibility-engraftment-kinetics-and-early-outcomes-from-kashmir-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:06:07Z","timestamp":1780715167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499760-non-cryopreserved-autologous-peripheral-blood-stem-cell-transplantation-for-lymphoma-in-a-resource-limited-setting-feasibility-engraftment-kinetics-and-early-outcomes-from-kashmir-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.110324","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}